Journal of Infectious Diseases and Medical Microbiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Editorial - Journal of Infectious Diseases and Medical Microbiology (2023) Volume 7, Issue 6

Malaria eradication efforts: Progress and obstacles

Elizabeth Liz *

Department of Medicine, University of Oxford, UK

*Corresponding Author:
Elizabeth Liz
Department of Medicine, University of Oxford, UK
E-mail: liz3@trop.ac.uk

Received:27-Oct-2023, Manuscript No. AAJIDMM-24-142937; Editor assigned: 30-Oct-2023, PreQC No. AAJIDMM-24-142937 (PQ); Reviewed: 13-Nov-2023, QC No. AAJIDMM-24-142937; Revised: 15-Nov-2023, Manuscript No. AAJIDMM-24-142937(R); Published: 20-Nov-2023, DOI: 10.35841/aajidmm-7.6.176

Citation: : Liz Elizabeth. Malaria eradication efforts: Progress and obstacles. J Infect Dis Med Microbiol. 2023;7(6):176.

Introduction

Malaria, a life-threatening disease caused by Plasmodium parasites and transmitted through the bites of infected Anopheles mosquitoes, continues to pose a significant global health challenge. Despite substantial progress in reducing the incidence and mortality of malaria over the past two decades, the goal of complete eradication remains elusive. This article explores the progress made in malaria eradication efforts, the strategies employed, and the obstacles that hinder the ultimate goal of a malaria-free world [1, 2].

The establishment of global initiatives such as the Roll Back Malaria Partnership and the Global Fund to Fight AIDS, Tuberculosis, and Malaria has galvanized international efforts and funding. Between 2000 and 2020, over $3 billion was invested annually in malaria control and elimination efforts [3, 4].

The development and deployment of innovative tools have been critical in the progress against malaria. These include Rapid Diagnostic Tests (RDTs), which allow for quick and accurate diagnosis, and the introduction of the RTS,S/AS01 malaria vaccine (Mosquirix), which provides partial protection against Plasmodium falciparum, the most deadly malaria parasite [5, 6].

Effective vector control measures, such as ITNs and IRS, remain the cornerstone of malaria prevention. In recent years, new approaches like the use of Long-Lasting Insecticidal Nets (LLINs) and targeted IRS campaigns have shown promise in reducing mosquito populations and interrupting transmission [7, 8].

Weak health systems in many malaria-endemic countries hinder the effective delivery of interventions. Challenges include inadequate infrastructure, limited healthcare workforce, and poor access to healthcare services, especially in rural and remote areas. Malaria is closely linked to poverty, and addressing the socioeconomic determinants of health is essential for sustainable malaria control. Additionally, environmental factors such as climate change and deforestation can influence mosquito breeding and transmission patterns, complicating eradication efforts [9, 10].

Conclusion

Malaria eradication is an ambitious but achievable goal. The progress made over the past two decades demonstrates that with the right strategies, resources, and commitment, significant gains can be made. However, overcoming the obstacles to eradication requires sustained effort, innovation, and global collaboration. Addressing drug and insecticide resistance, closing funding gaps, strengthening health systems, and tackling the broader socioeconomic and environmental determinants of malaria are essential steps towards a malaria-free world.

References

  1. Healer J, Cowman AF, Kaslow DC, et al. Vaccines to accelerate malaria elimination and eventual eradication. Cold Spring Harb Perspect Med. 2017;7(9):a025627.

    2. Indexed at, Google Scholar, Cross Ref

  2. Cowman AF, Healer J, Marapana D, et al. Malaria: biology and disease. Cell. 2016;167(3):610-24.

    3. Indexed at, Google Scholar, Cross Ref

  3. Aderinto N, Olatunji G, Kokori E, et al. A perspective on Oxford’s R21/Matrix-M™ malaria vaccine and the future of global eradication efforts. Malar J. 2024;23(1):16.

    4. Indexed at, Google Scholar, Cross Ref

  4. Kokori E, Olatunji G, Akinboade A, et al. Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts. Malar J. 2024;23(1):25.

    5. Indexed at, Google Scholar, Cross Ref

  5. Nissan H, Ukawuba I, Thomson M. Climate-proofing a malaria eradication strategy. Malar J. 2021;20:1-6.

    6. Indexed at, Google Scholar, Cross Ref

  6. Fornace KM, Diaz AV, Lines J, et al. Achieving global malaria eradication in changing landscapes. Malar J. 2021;20(1):69.

    7. Indexed at, Google Scholar, Cross Ref

  7. Cortés A, Deitsch KW. Malaria epigenetics. Cold Spring Harb Perspect Med. 2017;7(7):a025528.

    8. Indexed at, Google Scholar, Cross Ref

  8. González-Silva M, Rabinovich NR. Some lessons for malaria from the Global Polio Eradication Initiative. Malar J. 2021;20(1):210.

    9. Indexed at, Google Scholar, Cross Ref

  9. Newby G, Bennett A, Larson E, et al. The path to eradication: a progress report on the malaria-eliminating countries. Lancet. 2016;387(10029):1775-84.

    10. Indexed at, Google Scholar, Cross Ref

  10. Basu S, Sahi PK. Malaria: an update. Indian J Pediatr. 2017;84:521-8.

    11. Indexed at, Google Scholar, Cross Ref

Get the App